Rashida Orlova, Almira Vakhitova, Mark Gluzman, Eldar Topuzov, Petr Krivorotko, Alexandra Androsova, Ekaterina Serikova, Vitaly Skvortsov. "Results of the prospective randomized controlled trial VOG-01: Neoadjuvant endocrine therapy ribociclib + fulvestrant + GnRH-a versus chemotherapy 4 AC + 4 T for early HR+/HER2-negative breast cancer in premenopausal patients.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.606